CTU2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the CTU2 protein, also known as Cytoplasmic tRNA 2-Thiolation Protein 2. CTU2 is an essential component of the cellular machinery involved in the post-transcriptional modification of transfer RNAs (tRNAs). Specifically, CTU2 participates in the thiolation process, where a sulfur atom is added to the wobble position of certain tRNAs, a modification critical for the accurate and efficient translation of the genetic code during protein synthesis. The thiolation of tRNAs by CTU2 and its partner proteins enhances the fidelity of codon-anticodon pairing and helps in maintaining the stability of the translation process, which is crucial for proper cellular function and protein production.
Inhibitors of CTU2 are typically small molecules that bind to the active site of the protein or to key regions involved in its enzymatic activity, thereby disrupting its ability to facilitate tRNA thiolation. These inhibitors are valuable tools for studying the role of CTU2 in tRNA modification and the broader implications of tRNA thiolation on gene expression and cellular metabolism. By inhibiting CTU2, researchers can investigate how alterations in tRNA modification affect the translation process, potentially leading to changes in the expression and function of proteins. The chemical design of CTU2 inhibitors often involves understanding the precise molecular interactions between CTU2 and its substrates, allowing for the creation of compounds that are both selective and effective in modulating CTU2 activity. The study of CTU2 inhibitors provides critical insights into the complex network of processes that govern protein synthesis and highlights the importance of tRNA modifications in maintaining cellular homeostasis and function. The ongoing development of these inhibitors continues to deepen our understanding of the intricate mechanisms underlying translation and its regulation by tRNA modifications.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Buthionine sulfoximine | 83730-53-4 | sc-200824 sc-200824A sc-200824B sc-200824C | 500 mg 1 g 5 g 10 g | $286.00 $442.00 $1532.00 $2975.00 | 26 | |
Inhibitor of gamma-glutamylcysteine synthetase, can lead to depletion of glutathione and affect sulfur amino acid metabolism, potentially altering CTU2's function. | ||||||
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $312.00 $924.00 | 15 | |
Inhibitor of glutamine-utilizing enzymes, can disrupt the synthesis of glutathione and nucleotides, which could indirectly influence CTU2 activity. | ||||||
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $88.00 $291.00 $926.00 $2195.00 | ||
Glutamine analog that inhibits glutamine-dependent enzymes and could disrupt nucleotide biosynthesis, potentially altering CTU2 function. | ||||||
Acivicin | 42228-92-2 | sc-200498B sc-200498C sc-200498 sc-200498D | 1 mg 5 mg 10 mg 25 mg | $104.00 $416.00 $655.00 $1301.00 | 10 | |
An analog of glutamine that inhibits glutamine-utilizing enzymes and could thereby affect CTU2 by altering the nucleotide and amino acid metabolism. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, leading to a decrease in nucleotide synthesis, which could indirectly affect CTU2's role in tRNA modification. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Inhibits thymidylate synthase, which can lead to a nucleotide imbalance affecting RNA and tRNA synthesis, and potentially CTU2's activity. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA adducts that can disrupt DNA replication and transcription, potentially leading to effects on tRNA synthesis and CTU2 function. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, depleting deoxyribonucleotide pools and potentially affecting tRNA synthesis and CTU2 activity. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, could lead to decreased guanine nucleotide levels and indirectly affect the function of CTU2. | ||||||